EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 18, 2016
To place an electronic embedded link to this study and commentary in your story: Links will be live at the embargo time: http://archopht.jamanetwork.com/article.aspx?doi=10.1001/jamaophthalmol.2016.2906 http://archopht.jamanetwork.com/article.aspx?doi=10.1001/jamaophthalmol.2016.2942
In middle-aged and older individuals with type 2 diabetes, intake of at least 500 mg/d of dietary long-chain ω-3 polyunsaturated fatty acids, easily achievable with 2 weekly servings of oily fish, was associated with a decreased risk of sight-threatening diabetic retinopathy, according to a study published online by JAMA Ophthalmology.
The increasing prevalence of type 2 diabetes mellitus, coupled with an increased lifespan, has resulted in a steady rise of disability in older individuals with diabetes. A major concern for this population group is diabetic retinopathy (DR), a leading global cause of vision loss. Given the economic and societal burden of DR, developing effective strategies to prevent or at least delay its onset is a major public health issue. The retina is rich in long-chain ω-3 polyunsaturated fatty acids (LCω3PUFAs). Experimental models support dietary LCω3PUFA protection against DR, but clinical data are lacking.
Aleix Sala-Vila, D.Pharm., Ph.D., of the Lipid Clinic, Barcelona, and colleagues conducted a prospective study within the randomized clinical trial Prevencion con Dieta Mediterranea (PREDIMED), testing Mediterranean diets supplemented with extra virgin olive oil or nuts vs a control diet for primary cardiovascular prevention. The trial was conducted in primary health care centers in Spain. From 2003 to 2009, 3,614 individuals age 55 to 80 years with a previous diagnosis of type 2 diabetes were recruited. Full data were available for 3,482 participants (48 percent men; average age 67 years). Meeting the dietary LCω3PUFA recommendation of at least 500 mg/d for primary cardiovascular prevention was assessed by a validated food-frequency questionnaire.
Of the participants, a total of 2,611 (75 percent) met the target LCω3PUFA recommendation. During a median follow-up of 6 years, incident DR was diagnosed in 69 of the study participants. After adjusting for age, sex, intervention group, and lifestyle and clinical variables, participants meeting the LCω3PUFA recommendation at baseline (500 mg/d or greater) compared with those not fulfilling this recommendation (less than 500 mg/d) showed a 48 percent relatively reduced risk of incident sight-threatening DR.
“Our findings, which are consistent with the current model of the pathogenesis of DR and data from experimental models, add to the notion of fish-derived LCω3PUFA as a healthy fat,” the authors write.
(JAMA Ophthalmol. Published online August 18, 2016.doi:10.1001/jamaophthalmol.2016.2906; this study is available pre-embargo at the For The Media website.)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Commentary: Eat Your Fish or Go for Nuts
The PREDIMED study provides food for thought for those who wish to fight the complications of diabetes by clever eating, writes Michael Larsen, M.D., D.M.Sc., of Rigshospitalet-Glostrup and University of Copenhagen, Glostrup, Denmark, in an accompanying commentary.
“It seems a safe bet now to spread one’s food intake to include the gifts of our oceans and forests, while we consider how they can be protected for future generations and wait for large and ambitious studies of the effects of diet on diabetic retinopathy. The success of such studies in age-related macular degeneration shows that solid scientific information is worth waiting and working for.”
(JAMA Ophthalmol. Published online August 18, 2016.doi:10.1001/jamaophthalmol.2016.2942; this commentary is available pre-embargo at the For The Media website.)
Editor’s Note: Please see the article for additional information, including financial disclosures, funding and support, etc.
# # #